Evidence map›Paper›PMID 28415927›Full record

ArticleThe Journal of international medical research2017

Transarterial embolization for renal angiomyolipomas: A single centre experience in 79 patients.

Chengen Wang, Min Yang, Xiaoqiang Tong, Jian Wang, Haitao Guan, Guochen Niu, Ziguang Yan, Bihui Zhang, Yinghua Zou

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Urologic oncologic emergencies: a radiologist's guide.Abdominal radiology (New York) · 2026
    Review
  5. Embolic Agent Selection and Outcomes in Renal Angiomyolipoma Embolisation.Journal of medical imaging and radiation oncology · 2026
    Observational
  6. Article
  7. Renal bleeding: imaging and interventions in patients with tumors.Diagnostic and interventional radiology (Ankara, Turkey) · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chengen WangDepartment of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China.
Min YangDepartment of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China.
Xiaoqiang TongDepartment of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China.
Jian WangDepartment of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China.
Haitao GuanDepartment of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China.
Guochen NiuDepartment of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China.
Ziguang YanDepartment of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China.
Bihui ZhangDepartment of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China.
Yinghua ZouDepartment of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China.
Peking University First Hospital · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective To evaluate the long-term efficacy and safety of selective arterial embolization (SAE) in the treatment of renal angiomyolipomas (AMLs). Methods This was a retrospective review of medical records and imaging findings from patients with renal AMLs who attended our clinic and received SAE between January 2007 and January 2014. Only patents with complete medical records, preoperative computed tomography scans using typical imaging and follow-up data were included. Results A total of 79 patients were enrolled in the study. Technical and clinical success rates were 100% and 91% ( n = 72), respectively. Only two patients experienced major complications. Post-embolization syndrome (i.e. fever, abdominal pain, nausea or vomiting) was reported in 68 (86%) patients, but all symptoms were mild and resolved with conservative measures. Mean radiological and clinical follow-up periods were 16.8 and 35.9 months, respectively. In 75 (95%) patients, tumours decreased in size; mean ± SD tumour size significantly decreased from 8.4 ± 3.5 cm pre-embolization to 6.7 ± 3.0 cm post-embolization . Conclusions This study provides long-term evidence that SAE is a safe and effective method in the treatment of patients with renal AMLs.

Indexed as

Abdominal PainAdolescentAdultAgedAngiomyolipomaChildEmbolization, TherapeuticFemaleFeverHumansKidney NeoplasmsMaleMiddle AgedNauseaRenal ArteryRetrospective StudiesAngiomyolipomableomycin-lipiodol emulsionembolizationpolyvinyl alcoholrenaltuberous sclerosis

Identifiers

PMID28415927
PMCPMC5536643
OpenAlexW2582716670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.